Open-mkt buys · 90d
—
0 trades · 0 insiders
Open-mkt sales · 90d
$4.90M
4 trades · 2 insiders
Net · 90d
$-4.90M
Insiders on file
51
Daily buy vs sell · 90 days
■ Open-market buys (P) ■ Open-market sales (S) · daily dollar value by transaction date
Insiders
| Insider | Role | Trades | Bought | Sold | Last trade |
|---|---|---|---|---|---|
| Vaughn Bryan T | EVP, Diagnostics | 19 | $0 | $67.0K | 2026-09-01 |
| Meltzer Jonathan C | EVP, Operations | 19 | $0 | $298.8K | 2026-09-01 |
| Oyegunwa Akinbolade | EVP, CIO & CTO | 32 | $0 | $0 | 2026-09-01 |
| Caveney Brian J | SVP, Chief Medical Officer | 138 | $20.4K | $923.5K | 2026-09-01 |
| ANDERSON KERRII B | Director | 81 | $0 | $8.51M | 2026-08-17 |
| Schechter Adam H | President and CEO | 115 | $0 | $16.18M | 2026-08-11 |
| Summy Amy B. | EVP, Chief Marketing Officer | 83 | $0 | $2.55M | 2026-08-04 |
| Wilkinson Peter J | SVP, Chief Accounting Officer | 133 | $0 | $4.17M | 2026-08-03 |
| Kyle Kathryn W | EVP, Chief Legal Officer | 18 | $0 | $227.4K | 2026-07-02 |
| Bailey Megan D. | EVP, Pres, Central Labs & Intl | 50 | $0 | $0 | 2026-03-26 |
| Schroeder Mark S | EVP, President-Diagnostics Lab | 142 | $0 | $7.42M | 2026-03-26 |
| van der Vaart Sandra D | SVP, Global General Counsel | 134 | $0 | $8.53M | 2026-03-26 |
| GRAHAM ANITA Z | EVP, CHRO | 28 | $0 | $0 | 2026-03-26 |
| Kliphouse Kirsten Marie | Director | 13 | $0 | $0 | 2026-02-11 |
| Wang Julia Aijun | Chief Financial Officer, EVP | 15 | $0 | $0 | 2026-02-11 |
| Wengel Kathryn E | Director | 16 | $0 | $0 | 2026-02-11 |
| Davis Jeffrey A. | Director | 22 | $0 | $0 | 2026-02-11 |
| Rothman Paul | Director | 10 | $0 | $0 | 2026-02-11 |
| Parham Richelle P | Director | 32 | $0 | $1.78M | 2026-02-11 |
| Kong Garheng | Director | 40 | $0 | $0 | 2026-02-11 |
| NEUPERT PETER M | Director | 44 | $922.8K | $0 | 2026-02-11 |
| Sampson John H | Director | 1 | $0 | $0 | 2026-02-10 |
| Bulto Carulla Victor | Director | 2 | $0 | $0 | 2026-02-10 |
| Gilliland Dwight Gary | Director | 48 | $0 | $1.30M | 2025-07-30 |
| EISENBERG GLENN A | Executive Vice President | 217 | $0 | $35.32M | 2025-03-27 |
| BERBERIAN LANCE | SVP, Chief Information Officer | 163 | $0 | $5.28M | 2025-03-27 |
| DiVincenzo Jonathan P. | EVP, Pres, Central Labs & Intl | 24 | $0 | $107.7K | 2024-03-27 |
| Williams R Sanders | Director | 77 | $0 | $2.48M | 2024-02-07 |
| BELINGARD JEAN-LUC | Director | 86 | $0 | $7.29M | 2024-02-07 |
| Kirchgraber Paul R | CEO, Covance Drug Development | 76 | $0 | $3.95M | 2023-05-19 |
| Seltz Judith C | EVP, CHRO | 30 | $99.4K | $0 | 2023-03-30 |
| Pike Thomas | Pres & CEO Clinical Business | 1 | $0 | $0 | 2023-01-09 |
| KING DAVID P | President & CEO | 192 | $0 | $156.41M | 2020-05-05 |
| Uthgenannt Lisa J | Chief Human Resources Officer | 52 | $0 | $3.32M | 2019-09-04 |
| MITTELSTAEDT ROBERT E JR | Director | 52 | $0 | $2.96M | 2019-05-09 |
| Ratliff John D | CEO, Covance Drug Development | 29 | $0 | $0 | 2019-04-03 |
| Dodson Edward T | Principal Accounting Officer | 65 | $0 | $4.03M | 2019-04-01 |
| EBERTS F SAMUEL III | Chief Legal Officer, Secretary | 104 | $0 | $9.22M | 2019-02-12 |
| Gary M. Huff | CEO, LabCorp Diagnostics | 20 | $0 | $293.8K | 2018-09-04 |
| Boyle James T. Jr. | EVP,CEO of LabCorp Diagnostics | 99 | $0 | $24.18M | 2016-03-31 |
| Keller Deborah L | CEO, Covance Drug Development | 7 | $0 | $0 | 2016-03-11 |
| HERRING JOSEPH L | CEO of Covance Drug Division | 6 | $0 | $4.49M | 2015-07-31 |
| Brecher Mark E | Chief Medical Officer | 47 | $0 | $6.57M | 2015-03-31 |
| Hayes William B | Chief Financial Officer, EVP | 54 | $0 | $31.09M | 2014-06-06 |
| Rubenstein Arthur H | Director | 4 | $0 | $0 | 2014-05-08 |
| LANE WENDY E | Director | 25 | $0 | $151.6K | 2014-05-08 |
| WEIKEL M KEITH | Director | 13 | $0 | $385.1K | 2014-05-08 |
| Fonseca Lidia | Chief Information Officer | 17 | $0 | $1.88M | 2013-03-28 |
| COLES N ANTHONY | Director | 2 | $0 | $0 | 2013-02-15 |
| MAC MAHON THOMAS P | Director | 3 | $0 | $8.54M | 2012-09-06 |
| Walton Andrew Scott | EVP | 8 | $0 | $367.3K | 2012-04-09 |
Trade history
| Insider | Role | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|---|
| Caveney Brian J | EVP, Pres of BLS, CMO & CSO | A Award deriv | 2026-09-01 | 2026-09-03 | 3,000 | — | $0 | 7,170 | SEC↗ |
| Vaughn Bryan T | EVP and President, Diagnosti | A Award deriv | 2026-09-01 | 2026-09-03 | 1,500 | — | $0 | 5,204 | SEC↗ |
| Meltzer Jonathan C | EVP, COO | A Award deriv | 2026-09-01 | 2026-09-03 | 900 | — | $0 | 3,594 | SEC↗ |
| Oyegunwa Akinbolade | EVP, CIO & CTO | A Award deriv | 2026-09-01 | 2026-09-03 | 750 | — | $0 | 2,940 | SEC↗ |
| Oyegunwa Akinbolade | EVP, CIO & CTO | A Award deriv | 2026-09-01 | 2026-09-03 | 750 | — | $0 | 2,940 | SEC↗ |
| Meltzer Jonathan C | EVP, COO | A Award deriv | 2026-09-01 | 2026-09-03 | 900 | — | $0 | 3,594 | SEC↗ |
| Vaughn Bryan T | EVP and President, Diagnosti | A Award deriv | 2026-09-01 | 2026-09-03 | 1,500 | — | $0 | 5,204 | SEC↗ |
| Caveney Brian J | EVP, Pres of BLS, CMO & CSO | A Award deriv | 2026-09-01 | 2026-09-03 | 3,000 | — | $0 | 7,170 | SEC↗ |
| ANDERSON KERRII B | Director | S Sale | 2026-08-17 | 2026-08-18 | 3,000 | $318.02 | $954.1K | 6,563 | SEC↗ |
| ANDERSON KERRII B | Director | S Sale | 2026-08-17 | 2026-08-18 | 3,000 | $318.02 | $954.1K | 6,563 | SEC↗ |
| Schechter Adam H | President & CEO | S Sale | 2026-08-11 | 2026-08-12 | 4,669 | $320.37 | $1.50M | 102,565 | SEC↗ |
| Schechter Adam H | President & CEO, Director | S Sale | 2026-08-11 | 2026-08-12 | 4,669 | $320.37 | $1.50M | 102,565 | SEC↗ |
| Summy Amy B. | EVP, Chief Marketing Officer | S Sale | 2026-08-04 | 2026-08-06 | 924 | $306.74 | $283.4K | 6,956 | SEC↗ |
| Summy Amy B. | EVP, Chief Marketing Officer | S Sale | 2026-08-04 | 2026-08-06 | 924 | $306.74 | $283.4K | 6,956 | SEC↗ |
| Wilkinson Peter J | SVP, Chief Accounting Office | M Exercise deriv | 2026-08-03 | 2026-08-05 | 1,338 | — | $0 | 0 | SEC↗ |
| Wilkinson Peter J | SVP, Chief Accounting Office | S Sale | 2026-08-03 | 2026-08-05 | 82 | $309.22 | $25.4K | 1,770 | SEC↗ |
| Wilkinson Peter J | SVP, Chief Accounting Office | M Exercise | 2026-08-03 | 2026-08-05 | 1,338 | $209.25 | $280.0K | 3,108 | SEC↗ |
| Wilkinson Peter J | SVP, Chief Accounting Office | S Sale | 2026-08-03 | 2026-08-05 | 1,338 | $309.23 | $413.7K | 1,770 | SEC↗ |
| Wilkinson Peter J | SVP, Chief Accounting Office | M Exercise deriv | 2026-08-03 | 2026-08-05 | 1,338 | — | $0 | 0 | SEC↗ |
| Wilkinson Peter J | SVP, Chief Accounting Office | S Sale | 2026-08-03 | 2026-08-05 | 1,338 | $309.23 | $413.8K | 1,770 | SEC↗ |
| Wilkinson Peter J | SVP, Chief Accounting Office | M Exercise | 2026-08-03 | 2026-08-05 | 1,338 | $209.25 | $280.0K | 3,108 | SEC↗ |
| Wilkinson Peter J | SVP, Chief Accounting Office | S Sale | 2026-08-03 | 2026-08-05 | 82 | $309.22 | $25.4K | 1,770 | SEC↗ |
| Vaughn Bryan T | EVP and President, Diagnosti | S Sale | 2026-07-02 | 2026-07-06 | 234 | $286.19 | $67.0K | 6,746 | SEC↗ |
| Kyle Kathryn W | EVP, Chief Legal Officer | S Sale | 2026-07-02 | 2026-07-06 | 92 | $286.19 | $26.3K | 3,904 | SEC↗ |
| Vaughn Bryan T | EVP and President, Diagnosti | M Exercise deriv | 2026-07-01 | 2026-07-06 | 327 | — | $0 | 3,704 | SEC↗ |
| Kyle Kathryn W | EVP, Chief Legal Officer | M Exercise deriv | 2026-07-01 | 2026-07-06 | 256 | — | $0 | 2,008 | SEC↗ |
| Vaughn Bryan T | EVP and President, Diagnosti | M Exercise | 2026-07-01 | 2026-07-06 | 327 | — | $0 | 7,073 | SEC↗ |
| Vaughn Bryan T | EVP and President, Diagnosti | F Tax w/h | 2026-07-01 | 2026-07-06 | 93 | $283.88 | $26.4K | 6,980 | SEC↗ |
| Kyle Kathryn W | EVP, Chief Legal Officer | F Tax w/h | 2026-07-01 | 2026-07-06 | 73 | $283.88 | $20.7K | 3,996 | SEC↗ |
| Kyle Kathryn W | EVP, Chief Legal Officer | M Exercise | 2026-07-01 | 2026-07-06 | 256 | — | $0 | 4,069 | SEC↗ |
| Kyle Kathryn W | EVP, Chief Legal Officer | S Sale | 2026-06-08 | 2026-06-10 | 762 | $263.89 | $201.1K | 3,813 | SEC↗ |
| Schechter Adam H | President & CEO | S Sale | 2026-05-11 | 2026-05-13 | 5,903 | $254.50 | $1.50M | 107,234 | SEC↗ |
| Meltzer Jonathan C | EVP, Operations | S Sale | 2026-03-27 | 2026-03-30 | 839 | $267.05 | $224.1K | 3,620 | SEC↗ |
| Wilkinson Peter J | SVP, Chief Accounting Office | S Sale | 2026-03-27 | 2026-03-30 | 1,633 | $267.05 | $436.1K | 1,852 | SEC↗ |
| Bailey Megan D. | EVP, Pres, Central Labs & In | A Award | 2026-03-26 | 2026-03-30 | 1,184 | — | $0 | 5,332 | SEC↗ |
| Bailey Megan D. | EVP, Pres, Central Labs & In | F Tax w/h | 2026-03-26 | 2026-03-30 | 481 | $268.38 | $129.1K | 4,851 | SEC↗ |
| Kyle Kathryn W | EVP, Chief Legal Officer | F Tax w/h | 2026-03-26 | 2026-03-30 | 451 | $268.38 | $121.0K | 4,575 | SEC↗ |
| Kyle Kathryn W | EVP, Chief Legal Officer | A Award | 2026-03-26 | 2026-03-30 | 1,584 | — | $0 | 5,026 | SEC↗ |
| Meltzer Jonathan C | EVP, Operations | F Tax w/h | 2026-03-26 | 2026-03-30 | 711 | $268.38 | $190.8K | 4,459 | SEC↗ |
| Meltzer Jonathan C | EVP, Operations | A Award | 2026-03-26 | 2026-03-30 | 2,388 | — | $0 | 5,170 | SEC↗ |
| Oyegunwa Akinbolade | EVP, CIO & CTO | F Tax w/h | 2026-03-26 | 2026-03-30 | 382 | $268.38 | $102.5K | 5,064 | SEC↗ |
| Oyegunwa Akinbolade | EVP, CIO & CTO | A Award | 2026-03-26 | 2026-03-30 | 1,340 | — | $0 | 5,446 | SEC↗ |
| Summy Amy B. | EVP, Chief Marketing Officer | F Tax w/h | 2026-03-26 | 2026-03-30 | 1,836 | $268.38 | $492.7K | 7,880 | SEC↗ |
| Summy Amy B. | EVP, Chief Marketing Officer | A Award | 2026-03-26 | 2026-03-30 | 3,994 | — | $0 | 9,716 | SEC↗ |
| van der Vaart Sandra D | EVP, Corporate Affairs | F Tax w/h | 2026-03-26 | 2026-03-30 | 2,722 | $268.38 | $730.5K | 6,239 | SEC↗ |
| van der Vaart Sandra D | EVP, Corporate Affairs | A Award | 2026-03-26 | 2026-03-30 | 6,382 | — | $0 | 8,961 | SEC↗ |
| Vaughn Bryan T | EVP, Diagnostics | F Tax w/h | 2026-03-26 | 2026-03-30 | 451 | $268.38 | $121.0K | 6,746 | SEC↗ |
| Vaughn Bryan T | EVP, Diagnostics | A Award | 2026-03-26 | 2026-03-30 | 1,584 | — | $0 | 7,197 | SEC↗ |
| Wilkinson Peter J | SVP, Chief Accounting Office | A Award | 2026-03-26 | 2026-03-30 | 2,388 | — | $0 | 4,240 | SEC↗ |
| Wilkinson Peter J | SVP, Chief Accounting Office | F Tax w/h | 2026-03-26 | 2026-03-30 | 755 | $268.38 | $202.6K | 3,485 | SEC↗ |
| Caveney Brian J | EVP, Pres of ED, CMO & CSO | F Tax w/h | 2026-03-26 | 2026-03-30 | 863 | $268.38 | $231.6K | 36,492 | SEC↗ |
| Caveney Brian J | EVP, Pres of ED, CMO & CSO | A Award | 2026-03-26 | 2026-03-30 | 1,986 | — | $0 | 37,355 | SEC↗ |
| Caveney Brian J | EVP, Pres of ED, CMO & CSO | F Tax w/h | 2026-03-26 | 2026-03-30 | 4,042 | $268.38 | $1.08M | 35,369 | SEC↗ |
| Caveney Brian J | EVP, Pres of ED, CMO & CSO | A Award | 2026-03-26 | 2026-03-30 | 9,304 | — | $0 | 39,411 | SEC↗ |
| Schroeder Mark S | EVP, Pres Diagnostics & COO | A Award | 2026-03-26 | 2026-03-30 | 9,304 | — | $0 | 15,777 | SEC↗ |
| Schroeder Mark S | EVP, Pres Diagnostics & COO | F Tax w/h | 2026-03-26 | 2026-03-30 | 4,600 | $268.38 | $1.23M | 11,177 | SEC↗ |
| Schroeder Mark S | EVP, Pres Diagnostics & COO | A Award | 2026-03-26 | 2026-03-30 | 2,968 | — | $0 | 14,145 | SEC↗ |
| Schroeder Mark S | EVP, Pres Diagnostics & COO | F Tax w/h | 2026-03-26 | 2026-03-30 | 1,468 | $268.38 | $394.0K | 12,677 | SEC↗ |
| GRAHAM ANITA Z | EVP, CHRO | F Tax w/h | 2026-03-26 | 2026-03-30 | 2,879 | $268.38 | $772.7K | 5,185 | SEC↗ |
| GRAHAM ANITA Z | EVP, CHRO | A Award | 2026-03-26 | 2026-03-30 | 6,604 | — | $0 | 8,064 | SEC↗ |
| Schechter Adam H | President & CEO | A Award | 2026-03-26 | 2026-03-30 | 58,470 | — | $0 | 139,243 | SEC↗ |
| Schechter Adam H | President & CEO | F Tax w/h | 2026-03-26 | 2026-03-30 | 26,106 | $268.38 | $7.01M | 113,137 | SEC↗ |
| Schechter Adam H | President & CEO | S Sale | 2026-03-03 | 2026-03-05 | 8,705 | $279.96 | $2.44M | 80,773 | SEC↗ |
| van der Vaart Sandra D | EVP, Corporate Affairs | S Sale | 2026-02-27 | 2026-03-03 | 548 | $284.91 | $156.0K | 2,579 | SEC↗ |
| Caveney Brian J | EVP, Pres of ED, CMO & CSO | S Sale | 2026-02-24 | 2026-02-26 | 1,500 | $286.31 | $429.5K | 30,107 | SEC↗ |
| Wilkinson Peter J | SVP, Chief Accounting Office | S Sale | 2026-02-19 | 2026-02-23 | 666 | $277.94 | $185.1K | 1,852 | SEC↗ |
| Meltzer Jonathan C | EVP, Operations | S Sale | 2026-02-12 | 2026-02-13 | 87 | $290.42 | $25.3K | 2,782 | SEC↗ |
| ANDERSON KERRII B | Director | M Exercise deriv | 2026-02-11 | 2026-02-13 | 897 | — | $0 | 773 | SEC↗ |
| Davis Jeffrey A. | Director | M Exercise deriv | 2026-02-11 | 2026-02-13 | 897 | — | $0 | 773 | SEC↗ |
| Kliphouse Kirsten Marie | Director | M Exercise deriv | 2026-02-11 | 2026-02-13 | 897 | — | $0 | 773 | SEC↗ |
| Kong Garheng | Director | M Exercise deriv | 2026-02-11 | 2026-02-13 | 897 | — | $0 | 773 | SEC↗ |
| NEUPERT PETER M | Director | M Exercise deriv | 2026-02-11 | 2026-02-13 | 897 | — | $0 | 773 | SEC↗ |
| Parham Richelle P | Director | M Exercise deriv | 2026-02-11 | 2026-02-13 | 897 | — | $0 | 773 | SEC↗ |
| Wengel Kathryn E | Director | M Exercise deriv | 2026-02-11 | 2026-02-13 | 897 | — | $0 | 773 | SEC↗ |
| Rothman Paul | Director | M Exercise deriv | 2026-02-11 | 2026-02-13 | 897 | — | $0 | 773 | SEC↗ |
| Bailey Megan D. | EVP, Pres, Central Labs & In | M Exercise deriv | 2026-02-11 | 2026-02-13 | 403 | — | $0 | 2,827 | SEC↗ |
| Caveney Brian J | EVP, Pres of ED, CMO & CSO | M Exercise deriv | 2026-02-11 | 2026-02-13 | 740 | — | $0 | 4,170 | SEC↗ |
| GRAHAM ANITA Z | EVP, CHRO | M Exercise deriv | 2026-02-11 | 2026-02-13 | 356 | — | $0 | 2,401 | SEC↗ |
| Kyle Kathryn W | EVP, Chief Legal Officer | M Exercise deriv | 2026-02-11 | 2026-02-13 | 216 | — | $0 | 2,264 | SEC↗ |
| Meltzer Jonathan C | EVP, Operations | M Exercise deriv | 2026-02-11 | 2026-02-13 | 243 | — | $0 | 2,694 | SEC↗ |
| Oyegunwa Akinbolade | EVP, CIO & CTO | M Exercise deriv | 2026-02-11 | 2026-02-13 | 230 | — | $0 | 2,190 | SEC↗ |
| Schechter Adam H | President & CEO | M Exercise deriv | 2026-02-11 | 2026-02-13 | 3,656 | — | $0 | 22,214 | SEC↗ |
| Schroeder Mark S | EVP, Pres Diagnostics & COO | M Exercise deriv | 2026-02-11 | 2026-02-13 | 806 | — | $0 | 2,358 | SEC↗ |
| van der Vaart Sandra D | EVP, Corporate Affairs | M Exercise deriv | 2026-02-11 | 2026-02-13 | 376 | — | $0 | 1,141 | SEC↗ |
| Vaughn Bryan T | EVP, Diagnostics | M Exercise deriv | 2026-02-11 | 2026-02-13 | 323 | — | $0 | 4,031 | SEC↗ |
| Wang Julia Aijun | Chief Financial Officer, EVP | M Exercise deriv | 2026-02-11 | 2026-02-13 | 860 | — | $0 | 4,964 | SEC↗ |
| Wilkinson Peter J | SVP, Chief Accounting Office | M Exercise deriv | 2026-02-11 | 2026-02-13 | 536 | — | $0 | 2,128 | SEC↗ |
| Wilkinson Peter J | SVP, Chief Accounting Office | M Exercise deriv | 2026-02-11 | 2026-02-13 | 160 | — | $0 | 1,968 | SEC↗ |
| Summy Amy B. | EVP, Chief Marketing Officer | M Exercise deriv | 2026-02-11 | 2026-02-13 | 230 | — | $0 | 1,304 | SEC↗ |
| ANDERSON KERRII B | Director | M Exercise | 2026-02-11 | 2026-02-13 | 897 | — | $0 | 9,563 | SEC↗ |
| Davis Jeffrey A. | Director | M Exercise | 2026-02-11 | 2026-02-13 | 897 | — | $0 | 5,460 | SEC↗ |
| Kliphouse Kirsten Marie | Director | M Exercise | 2026-02-11 | 2026-02-13 | 897 | — | $0 | 3,160 | SEC↗ |
| Kong Garheng | Director | M Exercise | 2026-02-11 | 2026-02-13 | 897 | — | $0 | 13,739 | SEC↗ |
| NEUPERT PETER M | Director | M Exercise | 2026-02-11 | 2026-02-13 | 897 | — | $0 | 13,784 | SEC↗ |
| Parham Richelle P | Director | M Exercise | 2026-02-11 | 2026-02-13 | 897 | — | $0 | 3,366 | SEC↗ |
| Wengel Kathryn E | Director | M Exercise | 2026-02-11 | 2026-02-13 | 897 | — | $0 | 4,133 | SEC↗ |
| Rothman Paul | Director | M Exercise | 2026-02-11 | 2026-02-13 | 897 | — | $0 | 2,571 | SEC↗ |
| Bailey Megan D. | EVP, Pres, Central Labs & In | F Tax w/h | 2026-02-11 | 2026-02-13 | 138 | $289.89 | $40.0K | 4,148 | SEC↗ |
| Bailey Megan D. | EVP, Pres, Central Labs & In | M Exercise | 2026-02-11 | 2026-02-13 | 403 | — | $0 | 4,286 | SEC↗ |
| Caveney Brian J | EVP, Pres of ED, CMO & CSO | F Tax w/h | 2026-02-11 | 2026-02-13 | 211 | $289.89 | $61.2K | 31,607 | SEC↗ |
| Caveney Brian J | EVP, Pres of ED, CMO & CSO | M Exercise | 2026-02-11 | 2026-02-13 | 740 | — | $0 | 31,818 | SEC↗ |
| GRAHAM ANITA Z | EVP, CHRO | F Tax w/h | 2026-02-11 | 2026-02-13 | 109 | $289.89 | $31.6K | 1,460 | SEC↗ |
| GRAHAM ANITA Z | EVP, CHRO | M Exercise | 2026-02-11 | 2026-02-13 | 356 | — | $0 | 1,569 | SEC↗ |
| Kyle Kathryn W | EVP, Chief Legal Officer | F Tax w/h | 2026-02-11 | 2026-02-13 | 62 | $289.89 | $18.0K | 3,442 | SEC↗ |
| Kyle Kathryn W | EVP, Chief Legal Officer | M Exercise | 2026-02-11 | 2026-02-13 | 216 | — | $0 | 3,504 | SEC↗ |
| Meltzer Jonathan C | EVP, Operations | M Exercise | 2026-02-11 | 2026-02-13 | 243 | — | $0 | 2,939 | SEC↗ |
| Meltzer Jonathan C | EVP, Operations | F Tax w/h | 2026-02-11 | 2026-02-13 | 70 | $289.89 | $20.3K | 2,869 | SEC↗ |
| Oyegunwa Akinbolade | EVP, CIO & CTO | M Exercise | 2026-02-11 | 2026-02-13 | 230 | — | $0 | 4,174 | SEC↗ |
| Oyegunwa Akinbolade | EVP, CIO & CTO | F Tax w/h | 2026-02-11 | 2026-02-13 | 68 | $289.89 | $19.7K | 4,106 | SEC↗ |
| Schechter Adam H | President & CEO | S Sale | 2026-02-11 | 2026-02-13 | 5,273 | $284.38 | $1.50M | 87,343 | SEC↗ |
| Schechter Adam H | President & CEO | F Tax w/h | 2026-02-11 | 2026-02-13 | 1,521 | $289.89 | $440.9K | 89,478 | SEC↗ |
| Schechter Adam H | President & CEO | M Exercise | 2026-02-11 | 2026-02-13 | 3,656 | — | $0 | 90,999 | SEC↗ |
| Schroeder Mark S | EVP, Pres Diagnostics & COO | F Tax w/h | 2026-02-11 | 2026-02-13 | 259 | $289.89 | $75.1K | 6,473 | SEC↗ |
| Schroeder Mark S | EVP, Pres Diagnostics & COO | M Exercise | 2026-02-11 | 2026-02-13 | 806 | — | $0 | 6,732 | SEC↗ |
| van der Vaart Sandra D | EVP, Corporate Affairs | M Exercise | 2026-02-11 | 2026-02-13 | 376 | — | $0 | 3,225 | SEC↗ |
| van der Vaart Sandra D | EVP, Corporate Affairs | F Tax w/h | 2026-02-11 | 2026-02-13 | 99 | $289.89 | $28.7K | 3,126 | SEC↗ |
| Vaughn Bryan T | EVP, Diagnostics | F Tax w/h | 2026-02-11 | 2026-02-13 | 93 | $289.89 | $27.0K | 5,613 | SEC↗ |
| Vaughn Bryan T | EVP, Diagnostics | M Exercise | 2026-02-11 | 2026-02-13 | 323 | — | $0 | 5,706 | SEC↗ |
| Wang Julia Aijun | Chief Financial Officer, EVP | F Tax w/h | 2026-02-11 | 2026-02-13 | 245 | $289.89 | $71.0K | 1,817 | SEC↗ |
| Wang Julia Aijun | Chief Financial Officer, EVP | M Exercise | 2026-02-11 | 2026-02-13 | 860 | — | $0 | 2,062 | SEC↗ |
| Wilkinson Peter J | SVP, Chief Accounting Office | M Exercise | 2026-02-11 | 2026-02-13 | 160 | — | $0 | 2,564 | SEC↗ |
| Wilkinson Peter J | SVP, Chief Accounting Office | F Tax w/h | 2026-02-11 | 2026-02-13 | 46 | $289.89 | $13.3K | 2,518 | SEC↗ |
| Wilkinson Peter J | SVP, Chief Accounting Office | M Exercise | 2026-02-11 | 2026-02-13 | 536 | — | $0 | 2,564 | SEC↗ |
| Wilkinson Peter J | SVP, Chief Accounting Office | F Tax w/h | 2026-02-11 | 2026-02-13 | 160 | $289.89 | $46.4K | 2,404 | SEC↗ |
| Summy Amy B. | EVP, Chief Marketing Officer | M Exercise | 2026-02-11 | 2026-02-13 | 230 | — | $0 | 5,805 | SEC↗ |
| Summy Amy B. | EVP, Chief Marketing Officer | F Tax w/h | 2026-02-11 | 2026-02-13 | 83 | $289.89 | $24.1K | 5,722 | SEC↗ |
| ANDERSON KERRII B | Director | A Award deriv | 2026-02-10 | 2026-02-12 | 773 | — | $0 | 1,670 | SEC↗ |
| Bulto Carulla Victor | Director | A Award deriv | 2026-02-10 | 2026-02-12 | 773 | — | $0 | 909 | SEC↗ |
| Davis Jeffrey A. | Director | A Award deriv | 2026-02-10 | 2026-02-12 | 773 | — | $0 | 1,670 | SEC↗ |
| Kliphouse Kirsten Marie | Director | A Award deriv | 2026-02-10 | 2026-02-12 | 773 | — | $0 | 1,670 | SEC↗ |
| NEUPERT PETER M | Director | A Award deriv | 2026-02-10 | 2026-02-12 | 773 | — | $0 | 1,670 | SEC↗ |
| Parham Richelle P | Director | A Award deriv | 2026-02-10 | 2026-02-12 | 773 | — | $0 | 1,670 | SEC↗ |
| Wengel Kathryn E | Director | A Award deriv | 2026-02-10 | 2026-02-12 | 773 | — | $0 | 1,670 | SEC↗ |
| Sampson John H | Director | A Award deriv | 2026-02-10 | 2026-02-12 | 773 | — | $0 | 773 | SEC↗ |
| Rothman Paul | Director | A Award deriv | 2026-02-10 | 2026-02-12 | 733 | — | $0 | 1,670 | SEC↗ |
| Kong Garheng | Director | A Award deriv | 2026-02-10 | 2026-02-12 | 773 | — | $0 | 1,670 | SEC↗ |
| Caveney Brian J | EVP, Pres of ED, CMO & CSO | A Award deriv | 2026-02-10 | 2026-02-12 | 6,100 | — | $0 | 6,100 | SEC↗ |
| Caveney Brian J | EVP, Pres of ED, CMO & CSO | A Award deriv | 2026-02-10 | 2026-02-12 | 2,020 | — | $0 | 4,910 | SEC↗ |
| Bailey Megan D. | EVP, Pres, Central Labs & In | A Award deriv | 2026-02-10 | 2026-02-12 | 3,300 | — | $0 | 3,300 | SEC↗ |
| Bailey Megan D. | EVP, Pres, Central Labs & In | A Award deriv | 2026-02-10 | 2026-02-12 | 1,100 | — | $0 | 3,230 | SEC↗ |
| GRAHAM ANITA Z | EVP, CHRO | A Award deriv | 2026-02-10 | 2026-02-12 | 1,360 | — | $0 | 2,757 | SEC↗ |
| GRAHAM ANITA Z | EVP, CHRO | A Award deriv | 2026-02-10 | 2026-02-12 | 4,100 | — | $0 | 4,100 | SEC↗ |
| Summy Amy B. | EVP, Chief Marketing Officer | A Award deriv | 2026-02-10 | 2026-02-12 | 1,900 | — | $0 | 1,900 | SEC↗ |
| Summy Amy B. | EVP, Chief Marketing Officer | A Award deriv | 2026-02-10 | 2026-02-12 | 620 | — | $0 | 1,534 | SEC↗ |
| Oyegunwa Akinbolade | EVP, CIO & CTO | A Award deriv | 2026-02-10 | 2026-02-12 | 2,400 | — | $0 | 2,400 | SEC↗ |
| Oyegunwa Akinbolade | EVP, CIO & CTO | A Award deriv | 2026-02-10 | 2026-02-12 | 810 | — | $0 | 2,420 | SEC↗ |
| Wilkinson Peter J | SVP, Chief Accounting Office | A Award deriv | 2026-02-10 | 2026-02-12 | 440 | — | $0 | 2,664 | SEC↗ |
| Wilkinson Peter J | SVP, Chief Accounting Office | A Award deriv | 2026-02-10 | 2026-02-12 | 1,300 | — | $0 | 1,300 | SEC↗ |
| Wang Julia Aijun | Chief Financial Officer, EVP | A Award deriv | 2026-02-10 | 2026-02-12 | 7,100 | — | $0 | 7,100 | SEC↗ |
| Wang Julia Aijun | Chief Financial Officer, EVP | A Award deriv | 2026-02-10 | 2026-02-12 | 2,350 | — | $0 | 5,824 | SEC↗ |
| Vaughn Bryan T | EVP, Diagnostics | A Award deriv | 2026-02-10 | 2026-02-12 | 2,200 | — | $0 | 2,200 | SEC↗ |
| Vaughn Bryan T | EVP, Diagnostics | A Award deriv | 2026-02-10 | 2026-02-12 | 730 | — | $0 | 4,354 | SEC↗ |
| Kyle Kathryn W | EVP, Chief Legal Officer | A Award deriv | 2026-02-10 | 2026-02-12 | 2,700 | — | $0 | 2,700 | SEC↗ |
| Kyle Kathryn W | EVP, Chief Legal Officer | A Award deriv | 2026-02-10 | 2026-02-12 | 880 | — | $0 | 2,480 | SEC↗ |
| Meltzer Jonathan C | EVP, Operations | A Award deriv | 2026-02-10 | 2026-02-12 | 620 | — | $0 | 2,937 | SEC↗ |
| Meltzer Jonathan C | EVP, Operations | A Award deriv | 2026-02-10 | 2026-02-12 | 1,900 | — | $0 | 1,900 | SEC↗ |
| Schechter Adam H | President & CEO | A Award deriv | 2026-02-10 | 2026-02-12 | 31,700 | — | $0 | 31,700 | SEC↗ |
| Schechter Adam H | President & CEO | A Award deriv | 2026-02-10 | 2026-02-12 | 10,440 | — | $0 | 25,870 | SEC↗ |
| Meltzer Jonathan C | EVP, Operations | S Sale | 2026-02-10 | 2026-02-12 | 91 | $276.79 | $25.2K | 2,696 | SEC↗ |
| Bailey Megan D. | EVP, Pres, Central Labs & In | F Tax w/h | 2026-02-09 | 2026-02-10 | 23 | $274.01 | $6.3K | 3,883 | SEC↗ |
| Bailey Megan D. | EVP, Pres, Central Labs & In | F Tax w/h | 2026-02-09 | 2026-02-10 | 85 | $274.01 | $23.3K | 3,906 | SEC↗ |
| Summy Amy B. | EVP, Chief Marketing Officer | F Tax w/h | 2026-02-09 | 2026-02-10 | 80 | $274.01 | $21.9K | 5,575 | SEC↗ |
| GRAHAM ANITA Z | EVP, CHRO | F Tax w/h | 2026-02-09 | 2026-02-10 | 112 | $274.01 | $30.7K | 1,213 | SEC↗ |
| Kyle Kathryn W | EVP, Chief Legal Officer | F Tax w/h | 2026-02-09 | 2026-02-10 | 61 | $274.01 | $16.7K | 3,288 | SEC↗ |
| Meltzer Jonathan C | EVP, Operations | F Tax w/h | 2026-02-09 | 2026-02-10 | 82 | $274.01 | $22.5K | 2,787 | SEC↗ |
| Meltzer Jonathan C | EVP, Operations | S Sale | 2026-02-09 | 2026-02-10 | 88 | $275.53 | $24.2K | 2,869 | SEC↗ |
| Vaughn Bryan T | EVP, Diagnostics | F Tax w/h | 2026-02-09 | 2026-02-10 | 61 | $274.01 | $16.7K | 5,383 | SEC↗ |
| van der Vaart Sandra D | EVP, Corporate Affairs | F Tax w/h | 2026-02-09 | 2026-02-10 | 93 | $274.01 | $25.5K | 2,849 | SEC↗ |
| Schroeder Mark S | EVP, Pres Diagnostics & COO | F Tax w/h | 2026-02-09 | 2026-02-10 | 53 | $274.01 | $14.5K | 5,926 | SEC↗ |
| Schroeder Mark S | EVP, Pres Diagnostics & COO | F Tax w/h | 2026-02-09 | 2026-02-10 | 166 | $274.01 | $45.5K | 5,979 | SEC↗ |
| Wilkinson Peter J | SVP, Chief Accounting Office | F Tax w/h | 2026-02-09 | 2026-02-10 | 46 | $274.01 | $12.6K | 2,028 | SEC↗ |
| Schechter Adam H | President & CEO | F Tax w/h | 2026-02-09 | 2026-02-10 | 1,352 | $274.01 | $370.5K | 92,616 | SEC↗ |
| Oyegunwa Akinbolade | EVP, CIO & CTO | F Tax w/h | 2026-02-09 | 2026-02-10 | 51 | $274.01 | $14.0K | 3,944 | SEC↗ |
| Caveney Brian J | EVP, Pres of ED, CMO & CSO | F Tax w/h | 2026-02-09 | 2026-02-10 | 148 | $274.01 | $40.6K | 31,110 | SEC↗ |
| Caveney Brian J | EVP, Pres of ED, CMO & CSO | F Tax w/h | 2026-02-09 | 2026-02-10 | 32 | $274.01 | $8.8K | 31,078 | SEC↗ |
| Bailey Megan D. | EVP, Pres, Central Labs & In | M Exercise deriv | 2026-02-07 | 2026-02-10 | 67 | — | $0 | 2,130 | SEC↗ |
| Bailey Megan D. | EVP, Pres, Central Labs & In | M Exercise deriv | 2026-02-07 | 2026-02-10 | 222 | — | $0 | 2,197 | SEC↗ |
| Summy Amy B. | EVP, Chief Marketing Officer | M Exercise deriv | 2026-02-07 | 2026-02-10 | 222 | — | $0 | 914 | SEC↗ |
| GRAHAM ANITA Z | EVP, CHRO | M Exercise deriv | 2026-02-07 | 2026-02-10 | 367 | — | $0 | 1,397 | SEC↗ |
| Kyle Kathryn W | EVP, Chief Legal Officer | M Exercise deriv | 2026-02-07 | 2026-02-10 | 178 | — | $0 | 1,600 | SEC↗ |
| Meltzer Jonathan C | EVP, Operations | M Exercise deriv | 2026-02-07 | 2026-02-10 | 263 | — | $0 | 2,317 | SEC↗ |
| Vaughn Bryan T | EVP, Diagnostics | M Exercise deriv | 2026-02-07 | 2026-02-10 | 178 | — | $0 | 3,624 | SEC↗ |
| van der Vaart Sandra D | EVP, Corporate Affairs | M Exercise deriv | 2026-02-07 | 2026-02-10 | 353 | — | $0 | 1,517 | SEC↗ |
| Schroeder Mark S | EVP, Pres Diagnostics & COO | M Exercise deriv | 2026-02-07 | 2026-02-10 | 164 | — | $0 | 3,164 | SEC↗ |
| Schroeder Mark S | EVP, Pres Diagnostics & COO | M Exercise deriv | 2026-02-07 | 2026-02-10 | 517 | — | $0 | 3,328 | SEC↗ |
| Wilkinson Peter J | SVP, Chief Accounting Office | M Exercise deriv | 2026-02-07 | 2026-02-10 | 134 | — | $0 | 2,224 | SEC↗ |
| Schechter Adam H | President & CEO | M Exercise deriv | 2026-02-07 | 2026-02-10 | 3,249 | — | $0 | 15,430 | SEC↗ |
| Oyegunwa Akinbolade | EVP, CIO & CTO | M Exercise deriv | 2026-02-07 | 2026-02-10 | 149 | — | $0 | 1,610 | SEC↗ |
| Caveney Brian J | EVP, Pres of ED, CMO & CSO | M Exercise deriv | 2026-02-07 | 2026-02-10 | 111 | — | $0 | 2,890 | SEC↗ |
| Caveney Brian J | EVP, Pres of ED, CMO & CSO | M Exercise deriv | 2026-02-07 | 2026-02-10 | 517 | — | $0 | 3,001 | SEC↗ |
| Bailey Megan D. | EVP, Pres, Central Labs & In | M Exercise | 2026-02-07 | 2026-02-10 | 67 | — | $0 | 3,991 | SEC↗ |
| Bailey Megan D. | EVP, Pres, Central Labs & In | M Exercise | 2026-02-07 | 2026-02-10 | 222 | — | $0 | 3,924 | SEC↗ |
| Summy Amy B. | EVP, Chief Marketing Officer | M Exercise | 2026-02-07 | 2026-02-10 | 222 | — | $0 | 5,655 | SEC↗ |
| GRAHAM ANITA Z | EVP, CHRO | M Exercise | 2026-02-07 | 2026-02-10 | 367 | — | $0 | 1,325 | SEC↗ |
| Kyle Kathryn W | EVP, Chief Legal Officer | M Exercise | 2026-02-07 | 2026-02-10 | 178 | — | $0 | 3,349 | SEC↗ |
| Meltzer Jonathan C | EVP, Operations | M Exercise | 2026-02-07 | 2026-02-10 | 263 | — | $0 | 2,957 | SEC↗ |
| Vaughn Bryan T | EVP, Diagnostics | M Exercise | 2026-02-07 | 2026-02-10 | 178 | — | $0 | 5,444 | SEC↗ |
| van der Vaart Sandra D | EVP, Corporate Affairs | M Exercise | 2026-02-07 | 2026-02-10 | 353 | — | $0 | 2,942 | SEC↗ |
| Schroeder Mark S | EVP, Pres Diagnostics & COO | M Exercise | 2026-02-07 | 2026-02-10 | 164 | — | $0 | 6,145 | SEC↗ |
| Schroeder Mark S | EVP, Pres Diagnostics & COO | M Exercise | 2026-02-07 | 2026-02-10 | 517 | — | $0 | 5,981 | SEC↗ |
| Wilkinson Peter J | SVP, Chief Accounting Office | M Exercise | 2026-02-07 | 2026-02-10 | 134 | — | $0 | 2,074 | SEC↗ |
| Schechter Adam H | President & CEO | M Exercise | 2026-02-07 | 2026-02-10 | 3,249 | — | $0 | 93,968 | SEC↗ |
| Oyegunwa Akinbolade | EVP, CIO & CTO | M Exercise | 2026-02-07 | 2026-02-10 | 149 | — | $0 | 3,995 | SEC↗ |
| Caveney Brian J | EVP, Pres of ED, CMO & CSO | M Exercise | 2026-02-07 | 2026-02-10 | 517 | — | $0 | 31,147 | SEC↗ |
| Caveney Brian J | EVP, Pres of ED, CMO & CSO | M Exercise | 2026-02-07 | 2026-02-10 | 111 | — | $0 | 31,258 | SEC↗ |
| Bailey Megan D. | EVP, Pres, Central Labs & In | M Exercise deriv | 2026-02-06 | 2026-02-10 | 180 | — | $0 | 2,419 | SEC↗ |
| Summy Amy B. | EVP, Chief Marketing Officer | M Exercise deriv | 2026-02-06 | 2026-02-10 | 223 | — | $0 | 1,136 | SEC↗ |
| GRAHAM ANITA Z | EVP, CHRO | M Exercise deriv | 2026-02-06 | 2026-02-10 | 327 | — | $0 | 1,764 | SEC↗ |
| Kyle Kathryn W | EVP, Chief Legal Officer | M Exercise deriv | 2026-02-06 | 2026-02-10 | 180 | — | $0 | 1,778 | SEC↗ |
| Meltzer Jonathan C | EVP, Operations | M Exercise deriv | 2026-02-06 | 2026-02-10 | 267 | — | $0 | 2,580 | SEC↗ |
| Vaughn Bryan T | EVP, Diagnostics | M Exercise deriv | 2026-02-06 | 2026-02-10 | 180 | — | $0 | 3,802 | SEC↗ |
| van der Vaart Sandra D | EVP, Corporate Affairs | M Exercise deriv | 2026-02-06 | 2026-02-10 | 387 | — | $0 | 1,870 | SEC↗ |
| Schroeder Mark S | EVP, Pres Diagnostics & COO | M Exercise deriv | 2026-02-06 | 2026-02-10 | 743 | — | $0 | 3,845 | SEC↗ |
| Wilkinson Peter J | SVP, Chief Accounting Office | M Exercise deriv | 2026-02-06 | 2026-02-10 | 133 | — | $0 | 2,358 | SEC↗ |
| Schechter Adam H | President & CEO | M Exercise deriv | 2026-02-06 | 2026-02-10 | 4,460 | — | $0 | 18,679 | SEC↗ |
| Oyegunwa Akinbolade | EVP, CIO & CTO | M Exercise deriv | 2026-02-06 | 2026-02-10 | 180 | — | $0 | 1,759 | SEC↗ |
| Caveney Brian J | EVP, Pres of ED, CMO & CSO | M Exercise deriv | 2026-02-06 | 2026-02-10 | 670 | — | $0 | 3,518 | SEC↗ |
| Wang Julia Aijun | Chief Financial Officer, EVP | M Exercise deriv | 2026-02-06 | 2026-02-10 | 893 | — | $0 | 3,474 | SEC↗ |
| Bailey Megan D. | EVP, Pres, Central Labs & In | F Tax w/h | 2026-02-06 | 2026-02-10 | 72 | $277.20 | $20.0K | 3,702 | SEC↗ |
| Bailey Megan D. | EVP, Pres, Central Labs & In | M Exercise | 2026-02-06 | 2026-02-10 | 180 | — | $0 | 3,774 | SEC↗ |
| Summy Amy B. | EVP, Chief Marketing Officer | F Tax w/h | 2026-02-06 | 2026-02-10 | 92 | $277.20 | $25.5K | 5,433 | SEC↗ |
| Summy Amy B. | EVP, Chief Marketing Officer | M Exercise | 2026-02-06 | 2026-02-10 | 223 | — | $0 | 5,525 | SEC↗ |
| GRAHAM ANITA Z | EVP, CHRO | F Tax w/h | 2026-02-06 | 2026-02-10 | 119 | $277.20 | $33.0K | 958 | SEC↗ |
| GRAHAM ANITA Z | EVP, CHRO | M Exercise | 2026-02-06 | 2026-02-10 | 327 | — | $0 | 1,077 | SEC↗ |
| Kyle Kathryn W | EVP, Chief Legal Officer | F Tax w/h | 2026-02-06 | 2026-02-10 | 61 | $277.20 | $16.9K | 3,171 | SEC↗ |
| Kyle Kathryn W | EVP, Chief Legal Officer | M Exercise | 2026-02-06 | 2026-02-10 | 180 | — | $0 | 3,232 | SEC↗ |
| Meltzer Jonathan C | EVP, Operations | M Exercise | 2026-02-06 | 2026-02-10 | 267 | — | $0 | 2,785 | SEC↗ |
| Meltzer Jonathan C | EVP, Operations | F Tax w/h | 2026-02-06 | 2026-02-10 | 91 | $277.20 | $25.2K | 2,694 | SEC↗ |
| Vaughn Bryan T | EVP, Diagnostics | F Tax w/h | 2026-02-06 | 2026-02-10 | 61 | $277.20 | $16.9K | 5,266 | SEC↗ |
| Vaughn Bryan T | EVP, Diagnostics | M Exercise | 2026-02-06 | 2026-02-10 | 180 | — | $0 | 5,327 | SEC↗ |
| van der Vaart Sandra D | EVP, Corporate Affairs | M Exercise | 2026-02-06 | 2026-02-10 | 387 | — | $0 | 2,690 | SEC↗ |
| van der Vaart Sandra D | EVP, Corporate Affairs | F Tax w/h | 2026-02-06 | 2026-02-10 | 101 | $277.20 | $28.0K | 2,589 | SEC↗ |
| Schroeder Mark S | EVP, Pres Diagnostics & COO | F Tax w/h | 2026-02-06 | 2026-02-10 | 239 | $277.20 | $66.3K | 5,464 | SEC↗ |
| Schroeder Mark S | EVP, Pres Diagnostics & COO | M Exercise | 2026-02-06 | 2026-02-10 | 743 | — | $0 | 5,703 | SEC↗ |
| Wilkinson Peter J | SVP, Chief Accounting Office | F Tax w/h | 2026-02-06 | 2026-02-10 | 45 | $277.20 | $12.5K | 1,940 | SEC↗ |
| Wilkinson Peter J | SVP, Chief Accounting Office | M Exercise | 2026-02-06 | 2026-02-10 | 133 | — | $0 | 1,985 | SEC↗ |
| Schechter Adam H | President & CEO | M Exercise | 2026-02-06 | 2026-02-10 | 4,460 | — | $0 | 92,034 | SEC↗ |
| Schechter Adam H | President & CEO | F Tax w/h | 2026-02-06 | 2026-02-10 | 1,315 | $277.20 | $364.5K | 90,719 | SEC↗ |
| Oyegunwa Akinbolade | EVP, CIO & CTO | F Tax w/h | 2026-02-06 | 2026-02-10 | 61 | $277.20 | $16.9K | 3,846 | SEC↗ |
| Oyegunwa Akinbolade | EVP, CIO & CTO | M Exercise | 2026-02-06 | 2026-02-10 | 180 | — | $0 | 3,907 | SEC↗ |
| Caveney Brian J | EVP, Pres of ED, CMO & CSO | F Tax w/h | 2026-02-06 | 2026-02-10 | 209 | $277.20 | $57.9K | 30,630 | SEC↗ |
| Caveney Brian J | EVP, Pres of ED, CMO & CSO | M Exercise | 2026-02-06 | 2026-02-10 | 670 | — | $0 | 30,839 | SEC↗ |
| Wang Julia Aijun | Chief Financial Officer, EVP | M Exercise | 2026-02-06 | 2026-02-10 | 893 | — | $0 | 1,456 | SEC↗ |
| Wang Julia Aijun | Chief Financial Officer, EVP | F Tax w/h | 2026-02-06 | 2026-02-10 | 254 | $277.20 | $70.4K | 1,202 | SEC↗ |
| Bulto Carulla Victor | Director | A Award deriv | 2025-12-01 | 2025-12-03 | 136 | — | $0 | 136 | SEC↗ |
| Schechter Adam H | President & CEO | S Sale | 2025-11-11 | 2025-11-13 | 5,745 | $262.75 | $1.51M | 87,574 | SEC↗ |
| Oyegunwa Akinbolade | EVP, CIO & CTO | F Tax w/h | 2025-11-03 | 2025-11-04 | 107 | $257.84 | $27.6K | 3,727 | SEC↗ |
| Bailey Megan D. | EVP, Pres, Central Labs & In | F Tax w/h | 2025-11-03 | 2025-11-04 | 179 | $257.84 | $46.2K | 3,594 | SEC↗ |
| Oyegunwa Akinbolade | EVP, CIO & CTO | M Exercise deriv | 2025-11-01 | 2025-11-04 | 370 | — | $0 | 1,939 | SEC↗ |
| Bailey Megan D. | EVP, Pres, Central Labs & In | M Exercise deriv | 2025-11-01 | 2025-11-04 | 370 | — | $0 | 2,599 | SEC↗ |
| Oyegunwa Akinbolade | EVP, CIO & CTO | M Exercise | 2025-11-01 | 2025-11-04 | 370 | — | $0 | 3,834 | SEC↗ |
| Bailey Megan D. | EVP, Pres, Central Labs & In | M Exercise | 2025-11-01 | 2025-11-04 | 370 | — | $0 | 3,773 | SEC↗ |
| Parham Richelle P | Director | S Sale | 2025-10-31 | 2025-11-04 | 7,009 | $254.28 | $1.78M | 2,469 | SEC↗ |
| van der Vaart Sandra D | EVP, Chief Legal Officer | M Exercise deriv | 2025-08-13 | 2025-08-15 | 3,903 | — | $0 | 0 | SEC↗ |
| van der Vaart Sandra D | EVP, Chief Legal Officer | S Sale | 2025-08-13 | 2025-08-15 | 3,903 | $271.42 | $1.06M | 2,274 | SEC↗ |
| van der Vaart Sandra D | EVP, Chief Legal Officer | M Exercise | 2025-08-13 | 2025-08-15 | 3,903 | $131.43 | $513.0K | 6,177 | SEC↗ |
| Schechter Adam H | President & CEO | S Sale | 2025-08-11 | 2025-08-13 | 5,643 | $266.78 | $1.51M | 93,319 | SEC↗ |
| Gilliland Dwight Gary | Director | S Sale | 2025-07-30 | 2025-08-01 | 2,000 | $264.95 | $529.9K | 6,656 | SEC↗ |
| Wilkinson Peter J | SVP, Chief Accounting Office | S Sale | 2025-07-29 | 2025-07-31 | 100 | $261.04 | $26.1K | 1,852 | SEC↗ |
| Wilkinson Peter J | SVP, Chief Accounting Office | S Sale | 2025-07-29 | 2025-07-31 | 102 | $261.01 | $26.6K | 1,952 | SEC↗ |
| ANDERSON KERRII B | Director | S Sale | 2025-07-24 | 2025-07-28 | 3,500 | $280.00 | $980.0K | 8,666 | SEC↗ |
| ANDERSON KERRII B | Director | S Sale | 2025-07-24 | 2025-07-28 | 3,500 | $280.00 | $980.0K | 8,666 | SEC↗ |
| ANDERSON KERRII B | Director | S Sale | 2025-07-01 | 2025-07-02 | 500 | $265.00 | $132.5K | 12,166 | SEC↗ |
| ANDERSON KERRII B | Director | S Sale | 2025-06-11 | 2025-06-12 | 500 | $260.00 | $130.0K | 12,666 | SEC↗ |
| Caveney Brian J | EVP, Pres of ED, CMO & CSO | S Sale | 2025-06-03 | 2025-06-05 | 2,000 | $247.00 | $494.0K | 30,067 | SEC↗ |
| Schechter Adam H | President & CEO | S Sale | 2025-05-12 | 2025-05-13 | 6,105 | $248.73 | $1.52M | 98,962 | SEC↗ |
| Wilkinson Peter J | SVP, Chief Accounting Office | S Sale | 2025-05-01 | 2025-05-05 | 829 | $242.27 | $200.8K | 2,054 | SEC↗ |
| van der Vaart Sandra D | EVP, Chief Legal Officer | S Sale | 2025-05-01 | 2025-05-05 | 1,900 | $238.36 | $452.9K | 2,244 | SEC↗ |
| Bailey Megan D. | EVP, Pres, Central Labs & In | M Exercise deriv | 2025-04-01 | 2025-04-03 | 204 | — | $0 | 2,969 | SEC↗ |
| Bailey Megan D. | EVP, Pres, Central Labs & In | M Exercise deriv | 2025-04-01 | 2025-04-03 | 4,083 | — | $0 | 3,173 | SEC↗ |
| Bailey Megan D. | EVP, Pres, Central Labs & In | F Tax w/h | 2025-04-01 | 2025-04-03 | 68 | $232.65 | $15.8K | 3,403 | SEC↗ |
| Bailey Megan D. | EVP, Pres, Central Labs & In | M Exercise | 2025-04-01 | 2025-04-03 | 204 | — | $0 | 3,471 | SEC↗ |
| Bailey Megan D. | EVP, Pres, Central Labs & In | F Tax w/h | 2025-04-01 | 2025-04-03 | 1,546 | $232.65 | $359.7K | 3,267 | SEC↗ |
| Bailey Megan D. | EVP, Pres, Central Labs & In | M Exercise | 2025-04-01 | 2025-04-03 | 4,083 | — | $0 | 4,813 | SEC↗ |
| Schroeder Mark S | EVP, Pres Diagnostics & COO | S Sale | 2025-03-28 | 2025-03-31 | 2,635 | $231.67 | $610.5K | 4,960 | SEC↗ |
| Summy Amy B. | EVP, Chief Marketing Officer | S Sale | 2025-03-28 | 2025-03-31 | 758 | $231.67 | $175.6K | 5,302 | SEC↗ |
| Oyegunwa Akinbolade | EVP, CIO & CTO | A Award | 2025-03-27 | 2025-03-31 | 688 | — | $0 | 3,662 | SEC↗ |
| Oyegunwa Akinbolade | EVP, CIO & CTO | F Tax w/h | 2025-03-27 | 2025-03-31 | 198 | $231.67 | $45.9K | 3,464 | SEC↗ |
| Wilkinson Peter J | SVP, Chief Accounting Office | F Tax w/h | 2025-03-27 | 2025-03-31 | 359 | $231.67 | $83.2K | 2,883 | SEC↗ |
| Wilkinson Peter J | SVP, Chief Accounting Office | A Award | 2025-03-27 | 2025-03-31 | 1,249 | — | $0 | 3,242 | SEC↗ |
| Caveney Brian J | EVP, Pres of ED, CMO & CSO | F Tax w/h | 2025-03-27 | 2025-03-31 | 2,109 | $231.67 | $488.6K | 32,067 | SEC↗ |
| Caveney Brian J | EVP, Pres of ED, CMO & CSO | A Award | 2025-03-27 | 2025-03-31 | 4,840 | — | $0 | 34,176 | SEC↗ |
| BERBERIAN LANCE | EVP, Special Advisor, Strate | A Award | 2025-03-27 | 2025-03-31 | 3,325 | — | $0 | 20,005 | SEC↗ |
| BERBERIAN LANCE | EVP, Special Advisor, Strate | F Tax w/h | 2025-03-27 | 2025-03-31 | 1,353 | $231.67 | $313.4K | 18,652 | SEC↗ |
| EISENBERG GLENN A | Executive Vice President | A Award | 2025-03-27 | 2025-03-31 | 8,305 | — | $0 | 41,550 | SEC↗ |
| EISENBERG GLENN A | Executive Vice President | F Tax w/h | 2025-03-27 | 2025-03-31 | 3,630 | $231.67 | $841.0K | 37,920 | SEC↗ |
| Schechter Adam H | President & CEO | F Tax w/h | 2025-03-27 | 2025-03-31 | 13,584 | $231.67 | $3.15M | 105,067 | SEC↗ |
| Schechter Adam H | President & CEO | A Award | 2025-03-27 | 2025-03-31 | 30,469 | — | $0 | 118,651 | SEC↗ |
| van der Vaart Sandra D | EVP, Chief Legal Officer | A Award | 2025-03-27 | 2025-03-31 | 3,325 | — | $0 | 5,496 | SEC↗ |
| van der Vaart Sandra D | EVP, Chief Legal Officer | F Tax w/h | 2025-03-27 | 2025-03-31 | 1,352 | $231.67 | $313.2K | 4,144 | SEC↗ |
| Schroeder Mark S | EVP, Pres Diagnostics & COO | F Tax w/h | 2025-03-27 | 2025-03-31 | 2,205 | $231.67 | $510.8K | 7,595 | SEC↗ |
| Schroeder Mark S | EVP, Pres Diagnostics & COO | A Award | 2025-03-27 | 2025-03-31 | 4,840 | — | $0 | 9,800 | SEC↗ |
| Summy Amy B. | EVP, Chief Marketing Officer | F Tax w/h | 2025-03-27 | 2025-03-31 | 562 | $231.67 | $130.2K | 6,060 | SEC↗ |
| Summy Amy B. | EVP, Chief Marketing Officer | A Award | 2025-03-27 | 2025-03-31 | 2,077 | — | $0 | 6,622 | SEC↗ |
| ANDERSON KERRII B | Director | S Sale | 2025-03-05 | 2025-03-07 | 500 | $255.63 | $127.8K | 13,166 | SEC↗ |
| Schroeder Mark S | EVP, Pres Diagnostics & COO | M Exercise deriv | 2025-02-28 | 2025-03-04 | 3,903 | — | $0 | 0 | SEC↗ |
| Schroeder Mark S | EVP, Pres Diagnostics & COO | M Exercise | 2025-02-28 | 2025-03-04 | 3,903 | $131.43 | $513.0K | 10,299 | SEC↗ |
| Schroeder Mark S | EVP, Pres Diagnostics & COO | S Sale | 2025-02-28 | 2025-03-04 | 5,339 | $249.23 | $1.33M | 4,960 | SEC↗ |
| van der Vaart Sandra D | EVP, Chief Legal Officer | S Sale | 2025-02-25 | 2025-02-27 | 1,314 | $251.30 | $330.2K | 2,171 | SEC↗ |
| Summy Amy B. | EVP, Chief Marketing Officer | S Sale | 2025-02-24 | 2025-02-26 | 226 | $250.40 | $56.6K | 4,545 | SEC↗ |